N EUROSURGEONS and neuroradiologists have
tried different types of embolization to treat nonresectable cerebral arteriovenous malformations (AVM's). The variety of techniques used shows that there is no clear consensus about the best method of embolization. Luessenhop and his co-workers did pioneer work, and in 1960 published their first results of embolization of cerebral AVM's with plastic or steel emboli, s with a follow-up review 15 years later. 7 The factors governing successful embolization of cerebral AVM's with spheres or particles injected in the internal carotid or vertebral arteries have been described in detail. 9,1~176
Serbinenko x4 pioneered in a new field, using a latex balloon attached at the tip of a microcatheter; this was the first time that intra-arterial navigation into cortical arterial branches had become possible. His latex calibrated-leak balloon permits selective delivery of a chemotherapeutic agent in cases of glioblastoma, but it also possesses all the qualities required for safe injection of a polymerizing substance into a cerebral AVM. However, Serbinenko TM and other Russian authors have chosen to treat cerebral AVM's by the detachable balloon technique, which is not very different from surgical ligation of the feeders of an AVM.
Silastic calibrated-leak balloons have been extensively used by Kerbe# and Pevsner and Doppman. n These authors direct the balloon from the groin to one main feeder of the AVM, and embolize the nidus of the malformation with isobutyl-2-cyanoacrylate (bucrylate). This cyanoacrylic substance solidifies very quickly inside the AVM, occluding part or all of the balloon burst at end of injection of 0.5 ml Bucrylat; pt neurol intact 3 balloons became too big & were removed, one is intact; injection of 0.6 ml Bucrylat, balloon could not be deflated; deflated on pulling during 2nd emboliz, pt neurol intact 0.5 ml Bucrylat injected but balloon did not flU; pt neurol intact; emboliz of meningeal vessels with Ivalon 0.4 ml Bucrylat through PCA feeder; AVM still fills through MCA; pt neurol intact * Abbreviations: AVM = arteriovenous malformation; PCA = posterior cerebral artery; MCA = middle cerebral artery; ECA = external carotid artery; ACA = anterior cerebral artery; SAH = subarachnoid hemorrhage; pt = patient. abnormal vascular network. The obliteration of the nidus of the AVM should be the goal of a successful embolization.
Intraoperative embolization is another alternative. There is no doubt that in some cases it is easier to surgically expose, to damp, and to cannulate a cortical feeder than to reach it by intra-arterial navigation from the groin. Drake a and Allcock, et al., 1 tried to obliterate cerebral AVM's by intraoperative injection of particles of Gelfoam impregnated with Pantopaque, but it became obvious that the AVM rapidly recanalyzed in most cases. Sano, et al., la described embolization with a silicone polymer. Cromwell and Harris 2 have meticulously delineated the requirements of safe intraoperative embolization with bucrylate (Bucrylat).
Our series of 46 patients selected for embolization with bucrylate have been treated during three different periods. The first group of 22 patients was selected for treatment with the Silastic calibrated-leak balloon. During the second period, we almost completely abandoned this technique, and shifted to intraoperative embolization in 13 patients. The third period involves a group of 11 patients treated with our new latex calibrated-leak balloon with intra-arterial navigation, reserving intraoperative embolization for cases in which we were unable to reach the AVM feeders safely with the transfemoral technique.
Summary of Cases
The clinical material, technique, and results will be analyzed by the period in which treatment occurred.
First Period
In the period from January, 1978, to June, 1980, 22 patients were selected for embolization with bucrylate with the Silastic calibrated-leak balloon. Most of these patients had huge cerebral AVM's with multiple feeders, and they were either nonresectable or resectable with a high risk of a major neurological deficit. Eight patients presented with seizures, seven with subarachnoid hemorrhage (SAH), eight with progressive or permanent neurological deficit, and five with intractable migraines. In six cases, two of these symptoms were associated.
The delivery system was the Silastic calibrated-leak balloon.* We always tested the leak of the balloon before using it, and we had to reject approximately 10% of the balloons because there was a lateral leak or because the balloon burst too easily. After having propelled the tubing through the introducer, we removed the holder and adapted a No. 23 blunt needle to the Silastic tubing. Sometimes the balloon rapidly reached one of the main feeders of the AVM, but more often it became stuck either in the vertebral artery at the C-1 level or in the carotid siphon, with concomitant proximal coiling of the tubing in the vertebral or internal carotid artery. The tubing was then uncoiled by pulling down the introducer, followed by gentle injection of contrast material through the balloon, helping it to move forward and to enter one of the AVM feeders. It often took a long time to ease the balloon close enough to the AVM for safe embolization. In our hands, it was difficult to keep the Silastic balloon small after several inflations. Several times, overdistention resulted in the balloon bursting. On five occasions, balloon overdistention and bursting caused dissection of the vessel feeding the AVM, with immediate SAH, headache, vomiting, and seizures. Four patients totally recovered from these events without any neurological deficit, but one patient died from brain-stem hemorrhage. This type of complication may be avoided if the catheter is removed as soon as the balloon becomes bigger than the diameter of the catheterized vessel. Tables 1 and 2 summarize the results in this first group. Sixteen of the 22 patients had embolization. In * Silastic calibrated-leak balloon manufactured by Cook, Inc., Bloomington, Indiana. The pericallosal artery is still patent, proving that the delivery of glue was defmitely down into the AVM. The caliber of the arteries has decreased, and the flow through the AVM is slower, f: Selective angiography before embolization through the inflated calibrated-leak balloon, which was positioned distally in the PCA close to the AVM (arrow). g: After embolization, there was no f'dling of the AVM through the PCA. The patient still had homonymous quadrantanopsia.
posterior cerebral artery (PCA) had their malformation completely obliterated (Fig. 1) . The other 14 patients had partial obliteration of the AVM (Fig. 2 ) (less than 30% in nine cases). Four patients had transient neurological deficit with complete recovery. The only permanent neurological deficit was contralateral homonymous hemianopsia or quadrantanopsia in five cases of embolization of the PCA feeders to the AVM. Two patients in this group had complete surgical resection.
The seizures did not increase in frequency after embolization, but the short follow-up period does not allow any conclusion as to whether they have decreased in number. Patients who were under medication for seizures before embolization are still under medication. We have not noted any repeat SAH among the patients who had one or more than one bleed before embolization, but here, also, the follow-up period is insufficient to draw any valuable conclusion.
Second Period
Between June, 1980, and January, 1981, 13 patients had intraoperative embolization with bucrylate. The criteria for selection of these patients were: 1) that the cortical feeder to the AVM was easy to expose surgically without major dissection of the brain, and 2) that the AVM was such that complete surgical resection would have been risky, either because of the importance of the steal phenomenon or because of the location of the AVM.
We used the criteria for embolization already described by Cromwell and Harris. 2 Embolization can be carried out 1) when it is certain that the catheterized vessel is an artery and not a vein, and 2) when the direction of contrast material flow is into the AVM only, without opacification of normal cortical vessels. The cortical artery feeding the AVM is clipped and cannulated with a No. 3 French catheter. Iodine material is then injected and its distribution monitored on the television screen and recorded on a videotape. Depending on the speed of flow through the malformation, a fast polymerizing time (1 second) or relatively slow polymerizing time (3 seconds) is chosen. We mix 1 89 gm of black tantalum powder of 1-# particles with 1 ml of Pantopaque. When the powder has been totally dissolved, two ampules of isobutyl-2-cyanoacrylate (1 ml of bucrylate) are added, and the whole is mixed together. This mixture will solidify in 3 to 4 seconds when in contact with blood. A mixture of 1 gm of tantalum powder with 0.3 ml of Pantopaque and 1 ml of bucrylate will solidify faster (1 to 2 seconds). The injection of bucrylate is carefully monitored and immediately discontinued as soon as we see that bucrylate is reaching the venous drainage of the malformation. Two or three different cortical feeders can be cannulated and embolized at the same session. Tables 3 and 4 summarize the results obtained in these 13 patients. Complete obliteration of the malformations was achieved in four cases. One lesion was a dominant-hemisphere parietal AVM fed by the middle cerebral artery (MCA) only, one was a right frontal prerolandic AVM fed by the anterior cerebral artery (ACA), and two were cerebellar AVM's fed by the superior cerebeUar artery. None of these four patients had surgical resection. Three of them had transient neurological complications, and the patient with the superior cerebellar malformation had permanent mild ataxia.
The other nine patients had only partial embolization, but the percentage of the malformation obliterated was 50% or more in eight cases (that is, more complete than in the first group of cases embolized with the Silastic calibrated-leak balloon). Five of the nine patients with partial embolization had complete surgical resection. The surgical dissection appeared to be faster, easier, and to cause less hemorrhage than without previous embolization. Four of these five patients are neurologically intact and one has a permanent quadrantanopsia. The total number of AVM's completely obliterated is, therefore, nine out of 13. The remaining four patients had partial embolization and did not have surgical resection; three of these are neurologically intact, but one patient with a superior cerebellar artery AVM has a residual left hemiparesis.
Third Period
Eleven patients were treated between January, 1981, and June, 1981 (Tables 5 and 6 ). A new calibrated-leak balloon made of latex was developed at that time. The malleability of latex is such that this balloon can be used in vessels 1 to 4 mm in diameter without distending the vessel.
These 11 patients underwent 12 procedures for embolization, with partial success in eight patients and complete resolution in two; embolization was not carried out in one. One of these patients (Case 39, Fig.  3 and Table 5 ) had a right frontal prerolandic AVM, with two main MCA feeders and a watershed area coming from the pericallosal artery. Both pericallosal arteries were opacified through the left carotid artery. This is the same patient as in Case 28 (Table 3) . She had initially undergone intraoperative embolization of one of the two MCA feeders, with compression of the left carotid artery in the neck to decrease the flow of the right pericallosal artery. In this case, 80% of the AVM was obliterated, including the watershed area, proving that both compartments of the AVM (MCA * Abbreviations: CT = computerized tomography; PCA = posterior cerebral artery; MCA = middle cerebral artery; ECA = external carotid artery; ACA = anterior cerebral artery; SAH = subarachoid hemorrhage; pt --patient.
~" See Case 39, Table 5 .
and ACA) intercommunicated. The remaining 20% of the AVM was completely obliterated by a second embolization with our latex calibrated-leak balloon a few weeks later. The patient had a transient clumsiness of the left hand and face. The second patient (Case 37, Table 5 ) in whom complete obliteration of the AVM was achieved had a right temporal malformation fed by one huge anterior temporal branch of the right PCA. This branch could not be catheterized through the vertebral artery, but it was reached through the right internal carotid and right posterior communicating artery (Fig. 4) . One patient in this third group had a permanent field defect and minor memory disturbances after embolization of the PCA feeding vessels. In two patients, the catheter became glued in the malformation, and they now live with the catheter in place, without apparent complication. A technical mistake was responsible for this complication in both cases.
Discussion

Natural History of Cerebral A VM's
The natural history of cerebral AVM's is not as well known as that of aneurysms, although it appears to be more benign. Very few series have been reported of unoperated patients with a long follow-up period. In 1970, Troupp, et al., TM reported 137 patients who were treated nonsurgically between 1942 and 1967. Ten percent had died as a result of their malformation, and 5% from other causes; 24% were disabled, 21% were in fair condition, and 40% were well. Troupp made a follow-up study of 102 of these patients until 1977. 15 At that time, only 20% of the patients were well, 10% were in fair condition, and 18% had died as a result of their malformation. The other patients were * Abbreviations: PCA = posterior cerebral artery; MCA = middle cerebral artery; ECA = external carotid artery; ACA = anterior cerebral artery; SAH = subarachnoid hemorrhage; pt = patient; AVM = arteriovenous malformation. disabled (20%), had died from other causes (7%), or were lost to follow-up review (25%). It seems that the most important factor influencing the prognosis was the location of the AVM. In that series, of 56 patients with frontal, temporal, and occipital AVM's, two died, and of 81 patients with parietal, central, and infratentorial AVM's, 21 died.
Forster, et al., 4 reviewed Olivecrona's series of 35 patients who were managed conservatively, and followed them for 15 years. A patient with epilepsy who never bled has a one in four chance of bleeding in 15 years. A patient who has bled once has a one in four chance of bleeding again in 4 years, and a patient who has bled twice has a one in four chance of bleeding again within a year. The size of the AVM is also a major prognostic factor. In a series of 166 cases, Drake, 3 found that the incidence of hemorrhage from small AVM's was extremely high (92%). 
Criteria for Embolization
We selected patients for embolization on the basis of intractable seizures, repeated SAH's, permanent residual neurological deficit after one bleed, and the personal decision of the patient after having been warned of the risk of the treatment compared to the risk of conservative management. If these conditions were satisfied, we decided if the malformation was surgically resectable without a major risk of neurological deficit. Drake a has reported his experience in the surgical management of 166 cases of cerebral AVM's. He considered as inoperable those malformations invading the brain stem, the major part of the corpus caUosum, the deep part of the basal ganglia, and the internal capsule. All the other cases needed particular evaluation of the risk, especially when the AVM's invaded the rolandic area or the speech and comprehension areas of the dominant hemisphere.
When surgical resection and/or embolization are contraindicated, especially in AVM's involving the basal ganglia, radiotherapy is offered to the patient as an alternative, if the target area is not too large. If a nidus of the AVM is more than 5 cm in diameter, the risk of radionecrosis of adjacent normal brain is probably high.
Among the resectable AVM's, we have no strict rules by which to decide if the best treatment is surgery alone, embolization alone, or embolization associated with surgical resection. In practice, our rationale is to start with embolization whenever we think it is possible to reach one main feeder of the malformation and to inject bucrylate safely, if there is no predictable risk of neurological complication. In fact, there were few resectable AVM's in our series (16 nonresectable AVM's involving the MCA, the ACA, and the PCA, where only partial obliteration of the malformation can be expected.
Different Materials for Embolization
The embolizing material that we have chosen in this series has always been bucrylate, and our experience with detachable balloons or solid particles has been voluntarily limited because we are convinced that the advantages of using bucrylate are greater than using balloons or particles. The results with detachable balloons published by Serbinenko 14 or by Romodanov, et al., 12 are not convincing because it is difficult to understand how an AVM can be occluded with proximal occlusion of a feeding vessel. The fact that an AVM is not filled by contrast material immediately after detachment of the balloon does not prove that it is obliterated. The lack of subtracted films, of angiograpliy in the capillary-venous phase, of opacification of the other cerebral vessels after embolization, and of follow-up review with repeated complete angiographic study makes it difficult to interpret their amazing results.
Embolization with particles is a well described technique that was proposed by Luessenhop and Spence, 8 and later by other authors. 9,1~176 If knowledge of the geometrical factors influencing the migration of the particles is important, we must recognize that the risk of particles lodging in normal cortical vessels is extremely high. Wolpert and Stein 2~ have treated 34 patients by 59 embolization procedures; emboli lodged in normal arteries on 38 occasions and in veins on two. They reported 20 neurological complications during embolization, 19 of which recovered completely and the last remained a permanent neurological deficit. The number of emboli migrating into the lungs is unknown. Because this type of embolization is not well controlled, and because of the risk of neurological deficit (which is in practice one way to know that the end point of the embolization has been reached), we have not used this technique.
We do not wish to imply that bucrylate is not difficult and dangerous to manipulate. The goal of embolization of an AVM is to obliterate the whole network of abnormal vessels that form the core of the malformation, and only a polymerizing substance filling this network and solidifying very quickly can achieve this goal. It is also absolutely imperative to deliver the polymerizing substance into the feeder of the AVM at its point of entry into the core of the malformation, with no injection of adjacent normal cortical vessels. A calibrated-leak balloon positioned in the feeder, or cannulation of the feeder intraoperatively, both allow selective injection of bucrylate into the AVM.
Risks of Bucrflate Embolization
Many complications can occur with the calibratedleak balloon. The balloon and the catheter can become glued if the catheter is not withdrawn quickly enough before the balloon is embedded in the cast of bucrylate. With experience and by greasing the extremity of the balloon catheter, this risk is low. We have seen that solid particles can easily pass through the AVM and embolize the lungs. This problem also exists when using bucrylate, and the time for solidification of the glue must be carefully adjusted to the speed of the flow and to the steal phenomenon through the AVM. In one of our patients with a frontal AVM (Fig. 5 ) that was embolized with a calibrated-leak balloon, some of the injected bucrylate passed through the AVM and partially occluded the superior longitudinal sinus above the torcula; however, the patient has remained asymptomatic. The hazard of occluding the venous part of the AVM without completely occluding the arterial feeders must also be kept in mind, with the associated risk of the AVM becoming swollen and bleeding. We have recently treated a patient (not included in this series) who underwent embolization intraoperatively with bucrylate. Two of three cortical feeders were embolized, and the AVM was almost completely obliterated with a very slow filling of the draining veins but with a good arterial flow remaining through the nonembolized feeder. The patient's condition was excellent immediately after embolization, but she developed aphasia and right hemiparesis 24 hours later. Computerized tomography showed swelling and intracerebral hemorrhage in the AVM. This was certainly due to the blood outflow being decreased more than the blood inflow by the surgical procedure, which provided easy cannulation of the two cortical feeders with no dissection of the AVM.
It should be emphasized that the superselective angiogram obtained by injection of contrast material through the calibrated-leak balloon before embolization must be carefully interpreted. The inflated balloon modifies tremendously the flow through the AVM, and sometimes induces spasm of the feeder, with minimal filling of the AVM. The absence of opacification of normal cortical feeders does not prove that they are not there, and when the trunk of the feeder is occluded by bucrylate, it is very likely that reflux can occur in normal cortical vessels which were not visible before.
Tissue Reaction
The amount of tissue reaction induced by bucrylate is not well known, and experimental studies show some discrepancy. White, et al., TM embolized branches of the celiac artery of pigs and reported severe arterial wall damage, gastric ulcers, and splenic and hepatic infarcts. On the other hand, Freeney, et al., 5 reported bucrylate injections in 10 patients for whom pathological studies were subsequently available, and found that inflammation was limited to a mild histiocytic reaction involving only the luminal portion of the vessels, with no modification of the wall or adventitia. Vinters, et al., x7 studied two specimens of surgically resected AVM's previously embolized with bucrylate, and found a brisk intimal foreign-body giant-cell reaction wherever bucrylate was present in a vessel, along with chronic inflammation in the vessel walls and adjacent brain parenchyma.
We have personally embolized 38 renal arteries of 21 dogs with bucrylate, and the kidneys were examined by one of our anatomopathologists (Dr. Wallace). Bucrylate and tantalum powder were identified in all the injected kidneys, and infarcts were present in 23 of them. Eleven of the 38 kidneys contained only bland occlusive and nonocclusive masses, with no inflammation or necrosis. In the remaining 27, some vessels showed evidence of inflammation. There was a wide variation in the severity of reactions: four G. Debrun, et al. dogs exhibited no inflammatory lesions in either kidney, three had inflammation and necrosis on one side and not on the other, and individual kidneys commonly showed an extreme variation in the severity of response in different areas. The most consistent relationship was between the presence of infarction and of inflammation; most of the kidneys with infarcts showed severe vasculitis, and none of those without infarcts exhibited any appreciable inflammation.
We must consider that injection of bucrylate into normal parenchyma and normal vessels is different from injection into abnormal vessels feeding an AVM. It must be emphasized that the neurological complications are generally due to reflux or direct injection of bucrylate into normal cortical vessels, but whenever bucrylate flUs only the abnormal vessels of the AVM (even in a very dangerous area like the left operculum), no neurological deficit occurs (Cases 44 and 45, Table 5 ). Visual field defects occur very frequently during embolization of AVM's of the PCA, because it is extremely difficult to deliver bucrylate exclusively into the feeders of the AVM while sparing the normal occipital cortical vessels.
One last criticism which can be made concerning bucrylate is that we do not know the possible longterm effects of the drug.
Calibrated-Leak Balloon or lntraoperative Embolization
Our rationale for embolization of an AVM is actually to try to deliver bucrylate into the AVM nidus. Our new latex calibrated-leak balloon offers a safer technique with no risk of bursting and concomitant dissection of the feeder of the AVM. This method seems particularly helpful for the obliteration of the main feeders arising from the PCA or from the pericallosal artery. The feeders from the MCA are sometimes more difficult to reach distally with the balloon, but this is not a major problem because these feeders can be easily cannulated intraoperatively without any dissection of the surrounding normal brain.
Intraoperative embolization appeared to be a good alternative when embolization cannot be performed with the calibrated-leak balloon. It seems that embolization before surgical resection makes the dissection easier, with less loss of blood. Eight patients underwent complete resection after partial embolization.
Results of Complete or Partial Embolization
Seven of the total 46 patients had no embolization. Among the 39 patients with embolization, nine cerebral AVM's have been completely obliterated after embolization with bucrylate. The 30 remaining patients had partial embolization. We are not aware of a case of delayed rebleeding after embolization.t ~-Since we wrote this article, we have had one case of intraoperative embolization which bled 24 hours after almost complete obliteration of the AVM. Computerized tomography revealed blood and swelling of the AVM.
Bucrylate embolization of AVM's The AVM's that were completely obliterated with bucrylate have not been resected, and it is too early to know the long-term results in these cases. For example, we have not been able to determine the possible effect of embolization on seizures. The patient in Case 24 (Table 3) had intractable seizures from her right temporal AVM, which was completely obliterated by bucrylate; however, we do not know whether she will need temporal artery resection later if there is no improvement of the seizures. All the patients who had severe migraine have been improved after embolization.
Angiographically, we usually see important modifications of the hemodynamics of the cerebral circulation; decreased sump effect from the AVM, and visualization of adjacent normal cortical vessels which were not filled before embolization. Due to the size of AVM's with multiple feeders and major steal phenomenon, they are dangerous to resect or embolize in one sitting; in these cases, vasogenic edema may result from the loss of autoregulation of the adjacent brain parenchyma. Partial embolization a few weeks before surgery may make resection safer.
Conclusions
Bucrylate seems to be the best polymerizing substance to obliterate the core of a cerebral AVM. With experience, we can anticipate that the number of cerebral AVM's that can be completely obliterated with bucrylate will increase. It seems reasonable to try embolization with a calibrated-leak balloon and to reserve intraoperative embolization to cases with contraindications or failure of the previous technique. A long-term follow-up review is needed to determine the precise effects of partial or complete embolization on rebleeding, on seizures, and on progressive neurological deficit.
